[TNXP] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
07-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -5.79%
YoY- -56.42%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 33,902 0 0 9,027 0 0 -
PBT -28,356 -33,005 -31,680 -28,981 -23,140 -26,417 -29,553 -2.72%
Tax 29,002 -1,790 5,611 0 -196 -19 -92,420 -
NP -28,356 -33,005 -34,084 -28,981 -27,395 -26,417 -29,553 -2.72%
Tax Rate - - - - - - - -
Total Cost 28,356 66,907 34,084 28,981 36,422 26,417 29,553 -2.72%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 -100.00 0.00 0.00 -254.17 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -85.71 -102.85 -111.06 -4.24 -244.55 -321.28 -419.18 -65.39%
EPS Diluted -85.71 -102.85 -111.06 -4.24 -244.55 -321.28 -419.18 -65.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.